Anna Di Benedetto Selected Research

Male Breast Neoplasms (Male Breast Cancer)

10/2018	Stanniocalcin 2 expression is associated with a favourable outcome in male breast cancer.
5/2017	A Case-Matched Gender Comparison Transcriptomic Screen Identifies eIF4E and eIF5 as Potential Prognostic Markers in Male Breast Cancer.
1/2017	Characterisation of male breast cancer: a descriptive biomarker study from a large patient series.
10/2016	HMG-CoAR expression in male breast cancer: relationship with hormone receptors, Hippo transducers and survival outcomes.
11/2015	Androgen receptor and antiandrogen therapy in male breast cancer.
11/2014	Antiandrogen therapy in metastatic male breast cancer: results from an updated analysis in an expanded case series.
6/2012	A comparative biomarker study of 514 matched cases of male and female breast cancer reveals gender-specific biological differences.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Anna Di Benedetto Research Topics

Disease

21	Breast Neoplasms (Breast Cancer) 01/2021 - 03/2006
19	Neoplasms (Cancer) 01/2021 - 03/2006
7	Male Breast Neoplasms (Male Breast Cancer) 10/2018 - 06/2012
4	Triple Negative Breast Neoplasms 02/2017 - 12/2015
3	Neoplasm Metastasis (Metastasis) 01/2021 - 04/2011
3	Disease Progression 12/2020 - 01/2008
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 10/2018 - 09/2010
2	Rare Diseases (Rare Disease) 08/2017 - 11/2014
1	Ataxia Telangiectasia (Louis Bar Syndrome) 01/2019
1	Anaplasia 01/2019
1	Ataxia (Dyssynergia) 01/2019
1	Lymphoma (Lymphomas) 05/2018
1	Glioma (Gliomas) 01/2017
1	Glioblastoma (Glioblastoma Multiforme) 01/2017
1	Obesity 10/2016
1	Ductal Carcinoma 07/2016
1	Residual Neoplasm 12/2015
1	Genomic Instability 04/2015
1	Colorectal Neoplasms (Colorectal Cancer) 09/2010
1	Seminoma 04/2010
1	Carcinoma (Carcinomatosis) 03/2006
1	Carcinogenesis 03/2006
1	Breast Diseases (Breast Disease) 03/2006

Drug/Important Bio-Agent (IBA)

13	Biomarkers (Surrogate Marker)IBA 01/2019 - 01/2008
9	Hormones (Hormone)IBA 12/2020 - 04/2011
6	Estrogen ReceptorsIBA 01/2021 - 10/2014
4	Proteins (Proteins, Gene)FDA Link 01/2019 - 03/2006
4	Phenobarbital (Luminal)FDA Link 01/2019 - 01/2008
4	Trastuzumab (Herceptin)FDA Link 11/2016 - 04/2013
3	Phosphotransferases (Kinase)IBA 01/2019 - 04/2015
3	Progesterone Receptors (Progesterone Receptor)IBA 10/2017 - 03/2006
2	MicroRNAs (MicroRNA)IBA 05/2018 - 11/2012
2	SilverIBA 10/2017 - 04/2011
2	Androgen Antagonists (Antiandrogens)IBA 11/2015 - 11/2014
2	Androgen Receptors (Androgen Receptor)IBA 11/2015 - 11/2014
2	ErbB Receptors (EGF Receptor)IBA 04/2013 - 09/2010
2	Tyrosine Kinase InhibitorsIBA 04/2013 - 09/2010
2	Biological ProductsIBA 06/2012 - 02/2007
1	TEA Domain Transcription FactorsIBA 01/2021
1	Histones (Histone)IBA 01/2019
1	LigandsIBA 10/2018
1	teleocalcinIBA 10/2018
1	Fibronectins (Fibronectin)IBA 10/2018
1	IntegrinsIBA 10/2018
1	Metalloproteases (Metalloproteinases)IBA 10/2018
1	antithrombin III-protease complexIBA 01/2018
1	Factor VIII (Coagulation Factor VIII)IBA 01/2018
1	fibrin fragment D (D-dimer)IBA 01/2018
1	Plasminogen InactivatorsIBA 01/2018
1	Eukaryotic Initiation Factor-4EIBA 05/2017
1	Everolimus FDA Link 05/2017
1	A-Form DNA (A-DNA)IBA 02/2017
1	N-acetyltalosaminuronic acid (NAT)IBA 01/2017
1	Caspase 8 (Caspase-8)IBA 01/2017
1	AnthracyclinesIBA 11/2016
1	Taxoids (Taxanes)IBA 11/2016
1	DNA (Deoxyribonucleic Acid)IBA 12/2015
1	Estrogen Receptor Modulators (Antiestrogen)IBA 11/2015
1	AndrogensIBA 11/2015
1	Calcitriol Receptors (Calcitriol Receptor)IBA 01/2015
1	Vitamin D FDA LinkGeneric 01/2015
1	Glucose (Dextrose)FDA LinkGeneric 11/2014
1	Gonadotropin-Releasing Hormone (GnRH)FDA Link 11/2014
1	Cyproterone AcetateIBA 11/2014
1	Capecitabine (Xeloda)FDA Link 04/2013
1	Lapatinib (GW572016)FDA Link 04/2013
1	Phospholipases (Phospholipase)IBA 03/2013
1	Protein Isoforms (Isoforms)IBA 06/2012
1	Monoclonal AntibodiesIBA 09/2010
1	Tissue ExtractsIBA 04/2010
1	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 04/2010
1	PlasminogenIBA 04/2010
1	Plasminogen Activator Inhibitor 1IBA 04/2010
1	Plasminogen Activator Inhibitor 2IBA 04/2010
1	Urokinase Plasminogen Activator ReceptorsIBA 04/2010
1	Plasminogen Activators (Plasminogen Activator)IBA 04/2010
1	Messenger RNA (mRNA)IBA 04/2010
1	Estrogen Receptor betaIBA 01/2008
1	Cyclin D1IBA 02/2007
1	Fluorouracil (Carac)FDA LinkGeneric 02/2007
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 02/2007
1	Biological FactorsIBA 02/2007
1	Estrogen Receptor alphaIBA 02/2007
1	human ERBB2 proteinIBA 03/2006
1	Epidermal Growth Factor (EGF)IBA 03/2006
1	Estrogens (Estrogen)FDA Link 03/2006
1	Indicators and Reagents (Reagents)IBA 03/2006
1	Microfilament Proteins (Actin Binding Proteins)IBA 03/2006

Therapy/Procedure

6	Therapeutics 12/2020 - 04/2013
5	Drug Therapy (Chemotherapy) 01/2021 - 02/2007
4	Neoadjuvant Therapy 01/2017 - 10/2014
1	Ligation 10/2017
1	Adjuvant Chemotherapy 03/2013